Avitas Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,674
Closed -$2.43M 195
2024
Q3
$2.43M Buy
4,674
+67
+1% +$35.8K 0.34% 78
2024
Q2
$2.5M Buy
4,607
+5
+0.1% +$2.64K 0.37% 68
2024
Q1
$2.39M Buy
4,602
+71
+2% +$35.3K 0.36% 73
2023
Q4
$2.14M Buy
+4,531
New +$2.1M 0.36% 81
2022
Q3
Sell
-4,904
Closed -$2.37M 193
2022
Q2
$2.37M Buy
+4,904
New +$2.43M 0.52% 59

Other funds holding ELV

Avitas Wealth Management's ELV Position: Q4 2024 in Review

Avitas Wealth Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 4,674 shares — an estimated $2.43M sold.

Avitas Wealth Management first reported a position in ELV in Q2 2022 and held it in 5 quarters. The position peaked at $2.5M in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Avitas Wealth Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Avitas Wealth Management sold 4,674 Elevance Health shares in Q4 2024, an estimated $2.43M.
  • Avitas Wealth Management first reported a position in Elevance Health in Q2 2022 and held it in 5 quarters.
  • Avitas Wealth Management's Elevance Health position peaked at $2.5M in Q2 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Avitas Wealth Management's 13F filing for Q4 2024, filed 27 Jan 2025.